Melissa Tosca
Director of Finance/CFO at KIORA PHARMACEUTICALS, INC.
Net worth: 48 665 $ as of 2024-06-29
Melissa Tosca active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2024-06-30 | - |
| Director of Finance/CFO | - | - | |
| Corporate Officer/Principal | 2022-09-12 | - |
Career history of Melissa Tosca
Former positions of Melissa Tosca
| Companies | Position | Start | End |
|---|---|---|---|
Neomorph, Inc.
 Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Director of Finance/CFO | - | - |
| Treasurer | - | - |
Training of Melissa Tosca
| University of Arizona | Undergraduate Degree |
Statistics
International
| United States | 4 |
Operational
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Neomorph, Inc.
Neomorph, Inc. Pharmaceuticals: MajorHealth Technology Neomorph, Inc. is an American venture-backed biotechnology company that focuses on discovering innovative new medicines against 'undruggable' targets to solve critical problems in human health. The company is headquartered in an undisclosed location and has a key collaboration with the Center for Protein Degradation at the Dana Farber Cancer Institute. Neomorph's team is comprised of industry-leading experts in protein degradation and molecular glues who are committed to advancing the science and technology of molecular glue drug discovery. The company's patient-first, science-driven approach is complemented by its dedication to a supportive and collaborative work environment. Neomorph was founded by Eric Fischer, Philip Chamberlain, Scott A. Armstrong, and Benjamin Ebert, with Philip Chamberlain serving as the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Melissa Tosca
- Experience
